EUVIMEDEUVIMED entdecken
Kommentar

A cross-kingdom alliance driving colorectal cancer

Lior Lobel

Cancer Cell · 2026

DOI: 10.1016/j.ccell.2026.03.006 ↗

Kurz gefasst

Kommentar in der Zeitschrift Cancer Cell, 2026. Verfasst von Lior Lobel. Beteiligte Einrichtung: The Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel. Electronic address: lior.lobel@biu.ac.il. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Candida albicans, Fusobacterium nucleatum. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Israel Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this issue of Cancer Cell, Li et al. show that Candida albicans and Fusobacterium nucleatum form a cross-kingdom interaction through Flo9-RadD binding that accelerates colorectal cancer (CRC) progression. Disrupting this interaction with L-arginine reduces tumor burden, highlighting targeting microbial cooperation as a potential therapeutic strategy for CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsCandida albicansFusobacterium nucleatumHumansAnimals

Autor:innen und Institutionen

  • The Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel. Electronic address: lior.lobel@biu.ac.il.

Förderung

  • Israel Science Foundation

Zitieren

APA

Lobel, L. (2026). A cross-kingdom alliance driving colorectal cancer. Cancer Cell. https://doi.org/10.1016/j.ccell.2026.03.006

Vancouver

Lobel L. A cross-kingdom alliance driving colorectal cancer. Cancer Cell. 2026. doi:10.1016/j.ccell.2026.03.006

BibTeX
@article{Lobel2026,
  author = {Lobel, Lior},
  title = {A cross-kingdom alliance driving colorectal cancer},
  journal = {Cancer Cell},
  year = {2026},
  doi = {10.1016/j.ccell.2026.03.006}
}
Kostenlos starten →